Is Exelixis Inc halal to invest in?

As of July 2026, Exelixis Inc EXEL is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Exelixis Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Exelixis Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Exelixis Inc?

Muslim investors may consider investing in Exelixis Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Exelixis Inc classified as HALAL?

Musaffa determines the Shariah status of Exelixis Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Exelixis Inc updated?

The Shariah compliance status of Exelixis Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Exelixis Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Exelixis Inc?

You can check the latest Shariah compliance status of Exelixis Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

EXEL Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Exelixis Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Exelixis Inc. Stock Analysis EXEL

United States Health Care Large Cap Report: Q1, 2026

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. The company is headquartered in Alameda, California and currently employs 1,077 full-time employees. The company went IPO on 2000-04-11. The firm has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, cabozantinib. The company is also advancing and evolving its product pipeline portfolio, including its lead investigational asset, zanzalintinib. Cabozantinib is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET and has been also approved as CABOMETYX tablets for advanced renal cell carcinoma, for previously treated hepatocellular carcinoma and for previously treated, radioactive iodine-refractory differentiated thyroid cancer, and as COMETRIQ capsules for progressive, metastatic medullary thyroid cancer. The firm's other two products are COTELLIC, an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of advanced melanoma and MINNEBRO an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved the treatment of hypertension in Japan.

Key Statistics of Exelixis Inc (EXEL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$55.18$56.06

Today's Open

$56.00

Volume

2.38M

P/E Ratio (TTM)

18.00

52 Week Range

$33.76$57.57

Market Cap

14.10B

Avg. Volume

2.71M

Dividend Yield

Financial Metrics & Statements of Exelixis Inc (EXEL)

Super Investors Invested in Exelixis Inc (EXEL)

FAQ's for Exelixis Inc (EXEL)

As of July 2026, Exelixis Inc EXEL is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Exelixis Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Exelixis Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Exelixis Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Exelixis Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Exelixis Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.